SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFM14A - Definitive proxy statement relating to merger or acquisition:
SEC Accession No. 0001193125-24-113909
Filing Date
2024-04-25
Accepted
2024-04-25 16:13:52
Documents
14

Document Format Files

Seq Description Document Type Size
1 DEFM14A d794805ddefm14a.htm DEFM14A 2248567
2 GRAPHIC g794805dsp1.jpg GRAPHIC 3840
3 GRAPHIC g794805dsp1aa.jpg GRAPHIC 81751
4 GRAPHIC g794805dsp1b.jpg GRAPHIC 2234
5 GRAPHIC g794805dsp1c.jpg GRAPHIC 2067
6 GRAPHIC g794805dsp1d.jpg GRAPHIC 2108
7 GRAPHIC g794805dsp1e.jpg GRAPHIC 2248
8 GRAPHIC g794805dsp1g.jpg GRAPHIC 15960
9 GRAPHIC g794805dsp2.jpg GRAPHIC 1228
10 GRAPHIC g794805g00a01.jpg GRAPHIC 58191
11 GRAPHIC g794805g01a05.jpg GRAPHIC 38687
12 GRAPHIC g794805g12m12.jpg GRAPHIC 48709
13 GRAPHIC g794805g29y58.jpg GRAPHIC 21231
14 GRAPHIC g794805g36g82.jpg GRAPHIC 44809
  Complete submission text file 0001193125-24-113909.txt   2681016
Mailing Address 270 LONGWOOD ROAD SOUTH HAMILTON A6 L8P 0A6
Business Address 270 LONGWOOD ROAD SOUTH HAMILTON A6 L8P 0A6 289-799-0891
Fusion Pharmaceuticals Inc. (Filer) CIK: 0001805890 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: DEFM14A | Act: 34 | File No.: 001-39344 | Film No.: 24876458
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)